EXHIBIT 23.1
Published on June 27, 2024
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated June 21, 2024, with respect to the consolidated financial statements of Acasti Pharma Inc., incorporated herein by
reference, and to the reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG LLP
Philadelphia, Pennsylvania
June 27, 2024
June 27, 2024